News
Seven days of antibiotics was noninferior to 14 days for treating Gram-negative bloodstream infections, supporting shorter ...
Rhubarb could help battle deadly antibiotic-resistant superbugs such as E. coli, suggests new research. Natural compounds ...
Picking up where traditional antibiotics are failing, two natural compounds have been shown effective in killing ...
Flightpath Biosciences, Inc., a clinical stage biotechnology company focused on the development of precision therapeutics targeting bacterial ...
Remnants of everything that humans ingest ends up in waste water, including medications that people may be taking, like ...
For well over a decade, scientists, health leaders, and global organisations have sounded the alarm on antimicrobial ...
Wockhardt announces its exit from the US generics market, shifting focus to its innovative antibiotic and biologicals ...
Results from studies that evaluate combination therapy versus monotherapy for gram-negative bacilli conflict with the common practice of use of double coverage.
Antibiotic innovation, rising female UTI cases, and diagnostic advances are key drivers shaping the future of the UTI market. CA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Urinary tract ...
Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday ...
Chinese biotech Brii Biosciences (HKEX: 2137) has licensed its experimental antibiotic BRII-693 to domestic pharma business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results